Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • china hydroxychloroquine sulfate cas747-36-4

Oct . 31, 2024 07:51 Back to list

china hydroxychloroquine sulfate cas747-36-4



Hydroxychloroquine Sulfate A Comprehensive Overview


Hydroxychloroquine sulfate, designated by the CAS number 747-36-4, is a medication primarily known for its use in the treatment of malaria, lupus erythematosus, and rheumatoid arthritis. Initially synthesized in the 1940s as a less toxic alternative to chloroquine, hydroxychloroquine has gained significant attention, particularly in recent years due to its potential role in the treatment of COVID-19.


Mechanism of Action


Hydroxychloroquine works by inhibiting the growth of parasites in the red blood cells, but its mechanism extends beyond anti-malarial properties. It is thought to interfere with the acidic environment within lysosomes, thereby disrupting the function of immune cells. This ability to modulate immune responses makes it beneficial in autoimmune diseases, where it helps in reducing inflammation and tissue damage.


Medical Uses


1. Malaria Treatment Hydroxychloroquine is effective against certain strains of Plasmodium, the parasite responsible for malaria. It is particularly useful in areas where malaria is resistant to chloroquine.


2. Autoimmune Conditions The drug is widely used in managing systemic lupus erythematosus (SLE) and rheumatoid arthritis. It provides symptomatic relief and helps in reducing the frequency and severity of flare-ups in patients.


3. COVID-19 Research During the early stages of the COVID-19 pandemic, hydroxychloroquine was proposed as a potential treatment option due to its antiviral properties. However, subsequent clinical trials have produced mixed results, leading to varying recommendations regarding its use in COVID-19 patients.


china hydroxychloroquine sulfate cas747-36-4

china hydroxychloroquine sulfate cas747-36-4

Safety and Side Effects


While hydroxychloroquine is generally considered safe for long-term use, it is not without potential side effects. Common side effects include gastrointestinal disturbances, nausea, and headaches. More severe but rare side effects may involve retinal damage, which necessitates regular eye examinations for long-term users.


Regulatory Status


In different countries, the regulatory status of hydroxychloroquine varies. In the United States, the Food and Drug Administration (FDA) approved hydroxychloroquine for specific uses, but it has cautioned against its use for COVID-19 outside of clinical trials due to insufficient evidence. Conversely, some countries have adopted it more broadly amidst the pandemic, reflecting the varying levels of trust in research outcomes.


Current Research and Future Directions


Ongoing research continues to explore the broader applications of hydroxychloroquine. Studies are being conducted to investigate its role in other viral infections, cancer therapies, and its capacity to modulate immune responses in various conditions. Furthermore, the implications of its use in COVID-19 management remain an active area of investigation, with researchers assessing different dosages and combinations with other antiviral drugs.


Conclusion


Hydroxychloroquine sulfate, with its diverse applications and historical significance in treating malaria and autoimmune diseases, remains a pivotal topic in both medical and pharmaceutical research. As our understanding of this drug evolves, particularly in the context of new challenges like emergent viruses, it exemplifies the complexities of drug repurposing and the critical need for evidence-based practice in medicine.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
htHaitian Creole
en_USEnglish afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu htHaitian Creole